title: Developmentally regulated changes in glucosidase II association with, and carbohydrate content of, the protein tyrosine phosphatase CD45.
abstract: Glucosidase II (GII) stably interacts with the external domain of CD45 in a carbohydrate-dependent manner. We have found that the association occurs in immature cells, but is significantly reduced in mature T cells. Using mannose-binding protein (MBP), in both FACS analysis and pull-down assays, we find that MBP can specifically recognize cell surface CD45 from immature, but not mature T cells. Analysis of thymocytes reveals increased MBP binding and GII association with CD45 in double-positive thymocytes compared with either double-negative or single-positive thymocytes. As well, the same pool of CD45 recognized by MBP can also associate with GII. Initial analysis of the basis of the interaction between CD45 and MBP suggests MBP binds two different glycoforms of CD45 based on the differential competition with glucose. Finally, inhibition of GII activity in cells that do not normally express MBP ligands results in significant increases in cell surface MBP ligands, including CD45. Taken together, these data suggest that the glucose content of the cell surface CD45 changes as thymocytes undergo maturation to mature T cells, and may be regulated by GII interactions. Such changes in the cell surface carbohydrate on CD45 may affect the development of thymocytes, perhaps via binding of CD45 on thymocytes to lectins on stromal cells.
authors.affiliation: Department of Medical Microbiology and Immunology, 6-70 Heritage Medical Research Centre, University of Alberta, Edmonton, Alberta, Canada, T6G 2S2.
authors.forename: T A
authors.initials: TA
authors.lastname: Baldwin
authors.forename: H L
authors.initials: HL
authors.lastname: Ostergaard
mesh_terms: D000818:Animals; D001667:Binding, Competitive; D050260:Carbohydrate Metabolism; D002241:Carbohydrates / Q000032:analysis; D002352:Carrier Proteins / Q000378:metabolism; D002478:Cells, Cultured; D037222:Collectins; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006023:Glycoproteins / Q000737:chemistry / Q000378:metabolism; D065089:Glycoside Hydrolase Inhibitors; D006596:Hexosaminidases / Q000737:chemistry; D017493:Leukocyte Common Antigens / Q000737:chemistry* / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D013601:T-Lymphocytes / Q000276:immunology*; D013950:Thymus Gland / Q000254:growth & development* / Q000276:immunology*; D014407:Tumor Cells, Cultured; D000520:alpha-Glucosidases / Q000378:metabolism*
chemical_list: D002241:Carbohydrates; D002352:Carrier Proteins; D037222:Collectins; D004791:Enzyme Inhibitors; D006023:Glycoproteins; D065089:Glycoside Hydrolase Inhibitors; D017493:Leukocyte Common Antigens; C034251:4-nitrophenyl-alpha-glucosidase; D006596:Hexosaminidases; D000520:alpha-Glucosidases